Clarity Pharma Ltd

Have updates for this profile? Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Clarity Pharma Ltd - overview

Established

1998

Location

-, -, UK

Primary Industry

Retail

About

Clarity Pharma Ltd is dedicated to enhancing patient care through innovative pharmaceutical products designed for specific health conditions, focusing on efficacy and bioavailability in treatment outcomes. Clarity Pharma Ltd was founded in 1998, specializing in pharmaceutical products. Since its inception, the company has maintained a commitment to developing solutions tailored to evolving healthcare needs from its headquarters in the United Kingdom. The founder's background in the pharmaceutical industry has shaped its strategic direction, although specific details regarding prior ventures are not available.


Clarity Pharma specializes in providing a suite of innovative pharmaceutical products aimed at enhancing patient care and treatment outcomes. The company’s core offerings include advanced formulations of medications designed to address specific health conditions, focusing on delivering effectiveness and improved bioavailability. These products are utilized in various therapeutic areas, such as chronic disease management and acute care, catering to both healthcare providers and patients. Clarity Pharma's client base primarily consists of hospitals, clinics, and pharmacies across targeted geographical markets, including the United Kingdom and select regions in Europe.


By focusing on developing solutions that meet evolving healthcare needs, Clarity Pharma aims to establish a strong presence in the pharmaceutical industry. Clarity Pharma generates revenue through direct sales of its pharmaceutical products to healthcare institutions and retailers. The company employs a streamlined transaction structure that facilitates efficient ordering and distribution processes. Clients typically engage in purchasing agreements that may include bulk orders or individual product sales, ensuring that healthcare providers have access to necessary medications when needed.


While specific pricing plans are not disclosed, clients benefit from competitive pricing structures based on volume and partnership agreements. Clarity Pharma’s flagship products are positioned to capture significant market share, supporting the company’s financial growth through a steady stream of transactions in the healthcare sector.


Primary Industry

Retail

Sub Industries

Retail, Drug Stores/Convenience Stores

Website

www.claritydtp.com

Total Amount Raised

Subscriber access only

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.